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Abstract
Affinity chromatography is one of the most selective and versatile forms
of liquid chromatography for the separation or analysis of chemicals in
complex mixtures. This method makes use of a biologically related agent
as the stationary phase, which provides an affinity column with the abil‑
ity to bind selectively and reversibly to a given target in a sample. This
review examines the early work in this method and various developments
that have lead to the current status of this technique. The general princi‑
ples of affinity chromatography are briefly described as part of this dis‑
cussion. Past and recent efforts in the generation of new binding agents,
supports, and immobilization methods for this method are considered.
Various applications of affinity chromatography are also summarized, as
well as the influence this field has played in the creation of other affin‑
ity-based separation or analysis methods.
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1 Introduction
Most samples in nature consist of a complex mixture of many sub‑
stances. This fact has led to the development of chemical separation
methods such as liquid chromatography to purify, analyze, or exam‑
ine the components of such samples. The variety of chemical inter‑
actions and formats that can be employed in these separations, as
based on the types of stationary phases and mobile phases that are
used, has resulted in the creation of many types of liquid chroma‑
tography [1]. For instance, reversed phase chromatography or nor‑
mal phase chromatography can be utilized to separate chemicals
based on their polarity, ion exchange chromatography makes use
of ionic interactions, and size exclusion chromatography separates
chemicals based on their size. Such methods can also be classified
as low-performance or high-performance techniques based on the
support materials that are used and the types of column efficiencies
that are obtained. The large variety of such methods has resulted in
liquid chromatographic methods being employed for the separation
or analysis of many types of chemicals in liquid-phase samples. As a
result, it is not surprising that liquid chromatography is a common
liquid-phase separation method that is found in both industrial set‑
tings and research laboratories [1].
Perhaps the most selective, versatile, and complex form of liq‑
uid chromatography is the method of affinity chromatography. This
method is a type of liquid chromatography that uses a biologically re‑
lated agent as the stationary phase [2–7]. As this definition suggests,
affinity chromatography is based on the reversible and specific bind‑
ing that is often found in biological interactions. Examples of these in‑
teractions include the binding of an antibody with its target (or anti‑
gen), the binding of a hormone with its receptor, and the interaction
of an enzyme with its substrate. This type of selective binding is used
in affinity chromatography by placing within the column one of the
interacting agents and immobilizing this agent to a support for use as
a stationary phase. This immobilized binding agent is called the “af‑
finity ligand,” and it forms the basis by which the complementary tar‑
get can be isolated or purified by the affinity column.
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Fig. 1 Examples of typical (a) application and (b) elution sequences for affinity chro‑
matography. The isocratic elution method in (b) uses the same solution for both sam‑
ple application and elution from the column. The nonspecific elution method in (b)
uses a separate solution for elution that has a different pH, ionic strength, polarity
or temperature from the solution used for sample application. The biospecific elu‑
tion methods in (b) make use of an elution buffer that contains an agent that will
compete with the affinity ligand for binding to the target (normal role) or that com‑
petes with the target for binding to the affinity ligand (reversed role).

2 General Principles of Affinity Chromatography
Figure 1 shows a few ways in which an immobilized affinity li‑
gand can be used in a chromatographic separation. In each of these
approaches, a sample that contains the desired target is applied to
the column in the presence of a mobile phase that has the correct
composition and pH to promote binding of the target to the affin‑
ity ligand. This mobile phase is often referred to as the “application
buffer” and represents the weak mobile phase for this column (i.e.,
the liquid phase in which the column will have its highest retention
of the target). When the sample is applied to the affinity column in
the presence of this mobile phase, the target will be retained but,
due to the selective nature of the immobilized binding agent, other
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components in the sample will tend to pass through the column in
the nonretained fraction or as a weakly retained peak. The retained
target is then eluted from the column and measured, collected for
further use, or passed onto a second method for further separation
or analysis.
There are several ways in which the retained target can be removed
from the affinity column, as shown in Fig. 1. If this target has only
moderately strong binding to the column (e.g., an association equi‑
librium constant of 105–106 M −1 or less), it may be possible to use iso‑
cratic elution. In this approach, known as weak affinity chromatogra‑
phy, the application buffer is utilized both to apply the sample to the
affinity column and to later elute the retained target. A more common
method is to use a step change or gradient to elute the retained target
after the nonretained sample components have left the column. This
approach, sometimes known as the “on/off” elution method, uses a
second mobile phase to cause the target to leave the column due to
dissociation or mass action, as is demonstrated in Fig. 1 through the
use of nonspecific elution or biospecific elution. The second mobile
phase that is used in this case is called the “elution buffer” and rep‑
resents the strong mobile phase for the column (i.e., a mobile phase
that leads to low target retention). After this elution buffer has re‑
moved the target from the column, the original buffer is reapplied
and the column is allowed to regenerate prior to the next sample be‑
ing passed through the column.
As will be shown in this review, there are many types of binding
agents, supports, and separation formats that can be employed in af‑
finity chromatography. These features, plus the high selectivity of
many affinity ligands, have made this method popular in the larges‑
cale purification of enzymes and biopharmaceuticals [2–4]. Other ap‑
plications have included the small-scale isolation of recombinant pro‑
teins, the analysis of specific chemicals in biological or pharmaceutical
samples, and the study of biological interactions [2–6]. The remain‑
der of this review will examine the history of affinity chromatogra‑
phy and consider events and trends that have led to the development
and current applications of this technique.
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3 The Origins of Affinity Chromatography
The first known report of a separation that used affinity chroma‑
tography occurred in the early 1900s. This was a period of time in
which the method of liquid chromatography itself was still in its in‑
fancy. Some work had already been carried out in the late 1800s for
liquid-phase separations based on the adsorption of chemicals to pla‑
nar supports [1]. In addition, the utilization of packed columns and
the adsorption of targets to a solid support had been explored in 1903–
1907 by Michael Tswett for the separation of plant pigments [8]. A few
years later, in 1910, Emil Starkenstein studied binding by the enzyme
α-amylase to a column containing insoluble starch [9]. The method
used by Starkenstein, which was based on the natural interactions that
occur between α-amylase and starch, this enzyme’s substrate, was not
only the first known example of affinity chromatography but was also
one of earliest examples of a separation in which liquid chromatogra‑
phy was used with an enzyme or protein.
Methods similar to the one used by Starkenstein were soon de‑
scribed by others who were working with the enzyme amylase. Ex‑
amples included several papers which appeared over the next few de‑
cades, such as work by Ambard in 1921 [10], Holmbergh in 1933 [11],
Tokuoka in 1937 [12], and Hockenhull and Herbert in 1945 [13]. In
one of these reports, a 300-fold purification of amylase was even re‑
ported [14]. This general approach was also adopted for the purifica‑
tion or isolation of other enzymes that had substrates which could be
obtained in a solid or powdered form and used as support materials.
For instance, in 1934 Northrup used edestin, a crystalline protein, to
purify the protease pepsin [14]. Lineweaver et al. employed polyga‑
lacturonase in 1949 as both a support and affinity ligand for binding
to alginic acid [15]. In addition, Grant and Robbins described work in
1957 in which they used powdered elastin to isolate the enzyme por‑
cine elastase [16].
As these efforts were made on the use of substrates and solid sup‑
ports to purify enzymes, parallel reports appeared on the purifica‑
tion of antibodies by their selective binding to biological ligands. This
type of work with antibodies was based on a report in 1920 by Land‑
steiner in which it was found that antibodies could bind “antigens”
(i.e., chemicals that had a specific and complementary structure to the
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antibodies) [17]. In addition, it was found that large antigens could
bind with polyclonal antibodies to form complexes that precipitated
from an aqueous solution. The result was the creation of a method
known as immunoprecipitation, which appeared in the 1930s as a tool
for antibody characterization and purification [18–20]. As an exam‑
ple, immunoprecipitation was utilized in 1934 by Kirk and Sumner to
purify antibodies for urease and to demonstrate that these antibodies
were proteins [18]. Although this particular approach was not yet at
the point where it would now be called “chromatography,” such work
did demonstrate that the use of selective binding for purification and
analysis was not limited to enzyme–substrate interactions but could
be extended to antibody–antigen binding, and perhaps other types of
biological systems.

4 Early Developments in Affinity Supports and Immobilization
Methods
The earliest affinity-based separations, as described in the previ‑
ous section, all made use of naturally occurring materials as both the
support and binding agent. Examples included the use of supports
such as insoluble starch for the isolation of amylase [9–13], polyga‑
lacturonase for alginic acid [15], crystalline edestin for pepsin [14],
and powdered elastin for elastase [16]. The reports that utilized im‑
munoprecipitation employed a similar scheme based on naturally oc‑
curring solid supports, but in these studies the support was the pre‑
cipitate that was created as the result of the specific binding between
an antigen and its antibodies [18–20].
The next step in the development of affinity-based separations was
the creation of supports which could be used for binding agents and
targets for which naturally occurring ligand/support combinations
were not available. This work first involved binding agents that were
attached to supports by means of noncovalent adsorption. One exam‑
ple of this occurred in 1935 when D’Alessandro and Sofia coated an‑
tigens onto charcoal or kaolin and used these modified supports to
isolate antibodies that were related to tuberculosis and syphilis [21].
A similar antibody-purification method that used antigens on kaolin
was described by Meyer and Pic in 1936 [22]. Although these supports
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were relatively easy to prepare, one issue in using a support prepared
by ligand adsorption was that the binding properties of such a mate‑
rial may not have good long-term stability due to gradual loss of the
binding agent [2].
Approaches for the creation of supports that contained covalently
linked binding agents soon began to appear. This approach was used
in 1936 by Landsteiner and van der Scheer, who adapted a diazo cou‑
pling method that had already been used to prepare hapten conjugates
[23]. In their modified approach, they used this method to couple var‑
ious haptens to chicken erythrocyte stroma. This modified material
was then used to isolate antibodies that could bind to the immobi‑
lized haptens. Another important advance took place in 1951 in work
by Campbell, Luescher and Lerman [24]. In their research, they acti‑
vated cellulose to give p-aminobenzylcellulose, which was then used
to immobilize bovine serum albumin (BSA). The resulting material
was employed in the isolation of anti- BSA antibodies that were pres‑
ent in pooled serum from rabbits that had previously been injected
and immunized with BSA [24].
Other reports that used binding agents covalently linked to solid
supports soon began to appear. For instance, the same method as
used by Campbell et al. was employed by Lerman to immobilized hap‑
tens in 1953 for “antibody chromatography” [25]. Lerman also used
this approach to prepare a support with an immobilized ligand for the
purification of mushroom tyrosinase [26]. Other reports using cova‑
lently linked antigens for antibody purification appeared in 1955 by
Manecke and Gillert, who used polyaminostyrene as the support [27],
and in 1958 by Sutherland and Campbell, who utilized glass beads
for antigen immobilization [28]. From 1957 through 1966, several re‑
views and additional papers appeared on methods for the covalent
immobilization of antigens, enzymes or antibodies to solid materi‑
als [29–35]. Much of this work focused on supports containing im‑
mobilized antibodies, antigens or haptens, but some reports related
to enzyme purification were published as well. Of particular interest
in this latter group were two papers by Arsenis and McCormick in
1964 and 1966, in which various flavin-cellulose supports were used
for the purification of flavokinase [36] and flavin mononucleotidede‑
pendent enzymes [37].
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Fig. 2 The cyanogen bromide (CNBr) immobilization method. This figure shows two
possible routes by which ligands can be coupled to a support.

There were a series of critical developments that next occurred
around the mid- to late-1960s. One of these developments was the
creation of beaded agarose by Hjerten in 1964 [38]. This material was
important because it was more efficient and more readily adaptable
than cellulose for use with proteins and biopolymers in liquid chro‑
matography. A second development, which occurred in 1967, was the
description of the cyanogen bromide immobilization method by Axen,
Porath, and Ernback (see Fig. 2) [39]. The value of this immobiliza‑
tion method was that it allowed for a general and relatively conve‑
nient means for covalently coupling peptides and proteins to polysac‑
charide-based materials. In 1968, Cuatrecasas, Wilchek, and Anfinsen
[40] combined these two approaches when they used the cyanogen
bromide method to immobilize nuclease inhibitors to beaded aga‑
rose. These supports were then placed into columns and used to pu‑
rify several enzymes, including carboxypeptidase A, α-chymotrypsin,
and staphylococcal nuclease [40]. This general method was adapted
by many others [2–6] and became known by the name “affinity chro‑
matography” [2–7, 40].
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Fig. 3 Number of publications including the term “affinity chromatography” and
that appeared between 1968 and 2013. These data were obtained through a search
that was conducted in April 2014 on the Web of Science.

5 The Modern Area of Affinity Chromatography
Immediately after 1968, there was rapid growth in the field of af‑
finity chromatography and in the applications of this method. This
growth is indicated in Fig. 3 by the way in which the number of publi‑
cations including the term “affinity chromatography” grew from only
a few in the late 1960s to around 1,000 papers per year or more by
the early 1980s. Over the last decade, this number has risen to around
1,500 papers per year, giving a total of over 43,000 publications on
this topic that have appeared between 1968 and 2013. This period of
time has also seen the creation of a large range of methods and appli‑
cations that make use of affinity chromatography. The remainder of
this review will briefly consider many of these developments.
5.1 Advances in Affinity Ligands
One way in which affinity chromatographic methods can be catego‑
rized is in terms of the type of binding agent that is present in the col‑
umn. As was noted earlier, the first binding agents used in this method
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were those that were based on the interactions of enzymes with their
substrates, inhibitors or cofactors and on the interactions of antibod‑
ies with their antigens. These two groups of interactions are still used
in many of the modern applications of affinity chromatography. Ex‑
amples include the use of affinity chromatography for enzyme puri‑
fication, antibody isolation, and the selective purification or removal
of antigen- or antibody-related targets from samples [2–6].
The use of a biological molecule as the binding agent in affinity
chromatography, such as an enzyme or antibody, is a method known as
bioaffinity chromatography or biospecific adsorption [2–6, 41]. There
are many natural binding agents that have been employed in affinity
columns, which has resulted in the development of several subcatego‑
ries for bioaffinity chromatography. The most common subcategory is
one which uses a ligand that is an antibody or antibody-related agent
(e.g., an antigen or an antibody fragment), giving a technique known
as immunoaffinity chromatography (IAC) [42–46].
Another subset of bioaffinity chromatography is lectin affinity chro‑
matography, which uses binding agents that consist of lectins (i.e.,
nonimmune system proteins that can bind to particular carbohydrate
residues) [41, 47–49]. Examples of lectins that are often used in affin‑
ity columns are concanavalin A (Con A), which can bind to α-D-glucose
or α-D-mannose residues, and wheat germ agglutinin (WGA), which
interacts with D-N-acetylglucosamine residues [3–6, 41, 49]. Some
other natural ligands that have been employed in bioaffinity chroma‑
tography are immunoglobulinbinding proteins like protein A or pro‑
tein G, which can be used for antibody purification or as secondary
binding agents to adsorb antibodies to a support [6, 41, 49–52]. In ad‑
dition, nucleic acids and polynucleotides can be utilized in bioaffinity
chromatography to purify enzymes and proteins that bind to DNA or
RNA, as well as to retain nucleic acids that have a complementary se‑
quence to the immobilized binding agent [53–55].
Various nonbiological binding agents have also been employed in
affinity chromatography. Some illustrations of this approach appeared
during the early creation of synthetic agents and modified supports
for the purification of enzymes and antibodies, as described in the
previous section. Other examples that began to appear in the 1970s
included the techniques of immobilized metal-ion affinity chroma‑
tography (IMAC) [56], dye-ligand affinity chromatography [57], and
boronate affinity chromatography [58], as illustrated in Fig. 4.
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Fig. 4 Examples of nonbiological ligands that are used in (a) boronate affinity chro‑
matography, (b) immobilized metal-ion affinity chromatography (IMAC), and (c)
dye-ligand affinity chromatography.

In IMAC, the affinity ligand is a metal ion that is bound to a chelating
agent on the support (e.g., Ni2+ on a support that contains iminodiacetic
acid, or IDA) [56, 59–62]. IMAC can retain peptides, proteins and other
targets that have electron donor groups, making this method popular in
molecular biology for the purification of histidine-tagged proteins and
in proteomics for the isolation of phosphorylated proteins [60]. Dye-li‑
gand affinity chromatography uses a ligand that is a synthetic dye, such
as Cibacron Blue 3GA [3, 57]. The good stability, low cost, and ability to
custom design these ligands for a given target have made dye-ligand af‑
finity chromatography popular for the large-scale purification of pro‑
teins and enzymes [63, 64]. Boronate affinity chromatography is based
on the use of boronic acid or a related derivative as a ligand. This type
of ligand can retain targets that contain cis-diol groups, such as cate‑
cholamines and many compounds with sugar residues (e.g., polysac‑
charides, glycoproteins, and ribonucleic acids) [65–67].
The last few decades have seen increasing interest in the genera‑
tion of new types of affinity ligands through a variety of techniques.
One example is a technique known as biomimetic affinity chroma‑
tography [63]. As the term “biomimetic” suggests, this method seeks
to generate or select a ligand that can mimic the binding of a desired
target to some natural compound. This approach includes the use of
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synthetic dyes as ligands, making dye-ligand affinity chromatography
a subset of these biomimetic techniques [63]. There are many ways in
which artificial ligands can be produced. Some examples of these ap‑
proaches are the use of phage display libraries, aptamer libraries, and
ribosome display libraries. The creation of affinity ligands through the
use of peptide libraries, combinatorial chemistry, and computer mod‑
eling has also been an area of active research [63, 68, 69].
An alternative approach that has been explored to create artificial
ligands is molecular imprinting [70–73]. In this technique, the affinity
ligand is a binding pocket for the target and is formed during creation
of the support. This material can be prepared by combining a known
portion of the desired target with a polymerization mixture that con‑
tains a cross-linking agent, an initiating agent for polymerization, and
one or more monomers with functional groups that can interact with
the target. As this mixture polymerizes and forms the support, pockets
are produced about the target that have a shape and set of functional
groups that complement the target’s structure. After this molecularly
imprinted polymer (MIP) has been generated, the target is removed and
the pockets in this material are utilized as affinity ligands to retain and
bind the same target in samples that are applied to this support [70–73].
5.2 Advances in Affinity Supports and Immobilization Methods
Another way affinity chromatography has continued to develop is in
the types of supports and immobilization methods that have been em‑
ployed in this technique. Carbohydrate-based materials such as aga‑
rose remain the most common media for preparative applications of
affinity chromatography. Features of these supports that make them
useful for large-scale purifications and sample pretreatment include
their low nonspecific binding, low cost, and ability to be used over a
broad pH range for elution or with solutions that are often employed
for column sterilization. These supports can also be employed with a
variety of immobilization methods [2–6, 49, 74]. The main downside
for many of these materials is their relatively low efficiency and their
ability to be used at only modest back pressures. A method with such
properties is sometimes known as low-performance (or column) af‑
finity chromatography [2, 75, 76].
Soon after beaded agarose was used in affinity chromatography,
alternative supports were considered for this method. Some of these
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materials were based on silica or glass beads, which provided better ef‑
ficiencies and mechanical stability than carbohydrate-based supports.
The use of such materials gave a method known as high performance
affinity chromatography or high-performance liquid affinity chromatog‑
raphy [6, 76–79]; however, these supports did require some prior mod‑
ification to minimize their nonspecific binding for biological agents [6].
A range of synthetic organic-based supports were also created for affin‑
ity chromatography. These latter supports included azalactone beads,
hydroxylated polystyrene, polyacrylamide derivatives, polyethersulfone,
and polymethacrylate derivatives, as well as hybrid materials like aga‑
rose–acrylamide and dextran–acrylamide copolymers. Like agarose,
these alternative supports have now been used with many affinity li‑
gands and immobilization methods [3–6, 32, 78, 79].
There are various forms in which the support can be used in af‑
finity chromatography. The most common form is that of a particu‑
late support that is packed within a column. This type of support may
consist of agarose or cellulose beads, silica particles, glass beads, or
particles of an organic polymer like azalactone or polyacrylamide.
Monolithic supports have also been used with affinity ligands over
the last decade, giving a method known as “affinity monolith chro‑
matography”; in this approach, a porous bed made of a continuous
material is used in the affinity column [75]. Monolith columns have
been prepared by using media such as agarose, silica, polymethac‑
rylate or other organic polymers, and cryogels (e.g., see Fig. 5) [75,
76, 79, 80]. Other support formats that have been utilized in affinity

Fig. 5 Typical procedure used to prepare an organic monolith based on a copolymer
of glycidyl methacrylate (GMA) and ethylene glycol dimethacrylate (EDMA) for use
in affinity monolith chromatography.
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chromatography have included fibers, membranes, nonporous par‑
ticulate supports, flow-through particles (e.g., perfusion media), and
expanded bed particles [79].
The approach that is most frequently used in modern affinity chro‑
matography to place ligands onto these supports is covalent immobi‑
lization. There are many methods that can be used for this purpose
[3–6, 49, 74, 78]. For example, this might make use of amine groups,
carboxylic acids, or sulfhydryl residues in the structure of a ligand
such as a protein or peptide. Alternative schemes can also sometimes
be employed, such as the use of aldehyde groups that are generated
through the oxidation of carbohydrate residues [49, 74, 81]. In addi‑
tion, many of these procedures can now be carried out by using kits
or preactivated supports that are commercially available [49, 74].
Physical adsorption, which was used in some early forms of affin‑
ity chromatography, is still used on occasion for ligand immobiliza‑
tion. This method is usually easy to carry out but can result in a li‑
gand that may wash from the column over time or may use a support
material that will have nonspecific binding to some sample compo‑
nents [74]. A common variation of this method is biospecific adsorp‑
tion, which uses a secondary ligand that is coupled within the column
to selectively adsorb the final desired affinity ligand. A few examples
of this approach are the use of immobilized streptavidin or avidin to
bind to affinity ligands that have been tagged with biotin, and the use
of immobilized protein A or protein G to adsorption antibodies to af‑
finity supports [41, 43, 49, 74].
Another method for ligand immobilization that has been of inter‑
est is entrapment or encapsulation [74]. One way to accomplish this
is to combine the affinity ligand with the chemicals that are used to
make an affinity support, such as occurs when a sol–gel is prepared
in the presence of a protein or other type of ligand [74]. It is also pos‑
sible to place large ligands like liposomes or membrane-based parti‑
cles within the pores of some supports (e.g., agarose) by altering the
size of the ligand particles through a process such as freeze-drying
[82, 83]. Another approach that has recently been used for entrap‑
ment is to place soluble proteins and other affinity ligands in porous
supports by at least partially blocking the support’s pores through the
use of a large capping agent [84, 85].
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5.3 Advances in Applications of Affinity Chromatography and
Related Methods
As was true during the initial development of affinity chromatog‑
raphy, one of the key applications for this method is its use in the se‑
lective purification of biochemicals. The variety of ligands and sup‑
ports that are now available have made this technique valuable for
both small- and large-scale purification methods. A small-scale exam‑
ple is the use of IMAC to isolate and purify histidine-tagged proteins,
as are often produced in molecular biology [60]. Important examples
of large-scale purifications include the use of various forms of affin‑
ity chromatography to isolate enzymes, recombinant proteins, and bi‑
opharmaceutical products [63, 64, 86–90].
The high selectivity of affinity ligands, and the creation of improved
support materials for these ligands, has also led to the growth of af‑
finity chromatography as an important tool for chemical analysis [2,
6, 76–80]. This has included the use of this method in fields that have
ranged from biochemistry and clinical chemistry to pharmaceutical
analysis and environmental science [88, 91–94]. Some of these appli‑
cations have used affinity chromatography as a means of binding to a
particular target and then measuring this target directly as it elutes
from the affinity column [6, 43, 46, 92–96]. In some cases, such as
chiral separations, an affinity column can be used to retain and re‑
solve multiple targets that bind to the affinity ligand [92, 97–100].
Many other examples have used affinity ligands, and especially anti‑
bodies, to extract a given target or group of targets prior to the anal‑
ysis of these compounds by a second method (e.g., reversed phase
chromatography, gas chromatography, capillary electrophoresis, or
mass spectrometry) [42–44, 96, 101, 102]. Affinity columns have also
been employed with various detection schemes for the indirect detec‑
tion of a target, such as occurs in the use of antibodies in chromato‑
graphic-based immunoassays or in schemes that employ post column
immunodetection to examine specific targets as they elute from more
traditional types of liquid chromatographic columns [44, 46, 95, 96,
102, 103]. Both the specificity and strong binding of many biological
ligands have also made affinity columns attractive in recent years as
components for the processing or analysis of targets by microscale an‑
alytical devices [96, 101, 104, 105].
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Another application for affinity chromatography has been the use
of this method in the study of biological interactions [106–111]. Zonal
elution is one approach that was used as early as 1973–1974 for this
purpose [112, 113] and has been employed with such systems as pro‑
tein–protein, drug–protein, and enzyme– inhibitor interactions [106,
107, 109]. This method makes use of the injection of a small amount
of a probe compound or solute onto an affinity column, and is usually
done in the presence of a competing agent or additive in the mobile
phase. This method can provide data on the binding strength of the
ligand to the injected probe/solute or additive and on the types of in‑
teractions that are present between these agents [107, 109]. Frontal
analysis, or frontal affinity chromatography (FAC), is an alternative
approach for binding studies that has been used since 1975 [114]. This
method involves the continuous application of a known concentration
of a target to an affinity column, with the results being used to find
the equilibrium constant(s) and number of binding sites for the tar‑
get with the affinity ligand [106, 107, 109]. In the early-to-mid 1990s,
similar zonal elution and frontal analysis schemes were adapted for
use in capillary electrophoresis, creating a set of methods now known
as affinity capillary electrophoresis (ACE) [115–119].
Work in the mid-1970s through early-1980s also lead to the devel‑
opment of various ways for examining the kinetics of biological inter‑
actions by using affinity chromatography. An early example of such
an approach was a variation on zonal elution that made use of bandbroadening measurements [106, 120–122]. Other methods that were
described for kinetic studies included those based on the split-peak ef‑
fect, peak decay analysis, and various peak fitting methods [106, 107,
109, 123–130]. Similar work was then conducted in the use of immo‑
bilized affinity ligands and flow through biosensors for kinetic stud‑
ies [108, 131]. One result of these efforts was the creation of sensors
and devices that could determine the degree or rate of a target–ligand
interaction at a surface by measuring changes in optical properties,
such as based on surface plasmon resonance (SPR) [131–133].

6 Conclusion
Over the last one hundred years, affinity chromatography has
grown from a method that could be used to isolate only a few enzymes
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or antibodies to a powerful technique that has a broad range of appli‑
cations in chemical separations and analysis. This growth has been
made possible by the availability of many binding agents, support ma‑
terials, and immobilization methods that can now be used with this
technique. These developments, in turn, have made it possible for af‑
finity chromatography to become an important separation method for
both the large- and small-scale purification of biochemicals. Other ap‑
plications that have appeared for this method have included its use
in the direct or indirect detection of targets and its combination with
other methods of chemical analysis. Affinity chromatography has also
become a valuable tool for the study of biological interactions and has
led to the creation of related affinity methods, such as the use of flowbased sensors to examine biological interactions and affinity capillary
electrophoresis. As a result of the many current applications for this
method, it is expected that affinity chromatography will continue to
grow and develop in the future as a vital tool in areas that span from
the production of biopharmaceuticals to clinical analysis, environmen‑
tal testing, pharmaceutical testing, and biomedical research.
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